NCT06732713 Swiss Ball Versus Frenkel Exercises Effects in Down Syndrome
| NCT ID | NCT06732713 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Down Syndrome |
| Study Type | INTERVENTIONAL |
| Enrollment | 32 participants |
| Start Date | 2024-10-11 |
| Primary Completion | 2025-01-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 32 participants in total. It began in 2024-10-11 with a primary completion date of 2025-01-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Down syndrome (or trisomy 21) is the most common genetic cause of intellectual disability, occurring in an estimated 1 in 800 births worldwide. Approximately 11,000 people with Down syndrome live in Australia and 250,000 in the USA. Individuals with Down syndrome present with several impairments such as hypotonia, ligament laxity, decreased muscle strength, insufficient muscular co-contraction, inadequate postural control, and disturbed proprioception. Frenkel exercises are a series of motions of increasing difficulty performed by patients to facilitate the restoration of balance and coordination. Frenkel exercises are used to bring back the rhythmic, smooth and movements. In recent years, Swiss Ball has been widely used as a new method of treatment to increase balance, strengthen core region of body muscles, and strengthen muscles that are effective in maintaining posture, coordination, and flexibility. The aim of this recent study is to compare the effects of two different therapeutic techniques i.e Frenkel versus Swiss ball exercises on static and dynamic balance in children with Down syndrome.
Eligibility Criteria
Inclusion Criteria: * Patients diagnosed with Down syndrome. * Age between 8 to 13 years. * Patient able to understand instructions necessary for intervention. * Independent standing and walking abilities. * Both the genders were included Exclusion Criteria: * Severe mental retardation. * Any heart deficit. * Visual impairments. * Musculoskeletal or mobility disorder. * Hearing impairements. * Signs of epilepsy or instability of atlanto axial joint
Contact & Investigator
Layba Marrium, MS*
PRINCIPAL INVESTIGATOR
Riphah International University
Frequently Asked Questions
Who can join the NCT06732713 clinical trial?
This trial is open to participants of all sexes, aged 8 Years or older, up to 13 Years, studying Down Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06732713 currently recruiting?
Yes, NCT06732713 is actively recruiting participants. Contact the research team at Imran.amjad@riphah.edu.pk for enrollment information.
Where is the NCT06732713 trial being conducted?
This trial is being conducted at Lahore, Pakistan.
Who is sponsoring the NCT06732713 clinical trial?
NCT06732713 is sponsored by Riphah International University. The principal investigator is Layba Marrium, MS* at Riphah International University. The trial plans to enroll 32 participants.